Search Login Register

Gadolinium DTPA (Magnevist) Summary

Description: A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)

Also Known As: Magnevist; Gadopentetic Acid; Gadopentetate Dimeglumine; Berlex Brand of Gadopentetate Dimeglumine; Gadolinium DTPA Dimeglumine Show All >>

Networked: 2047 relevant articles (138 outcomes, 267 trials/studies) for this Drug

Key Diseases for which Gadolinium DTPA is Relevant

  1. Neoplasms (Cancer) : 52 outcomes 63 studies in 620 results
  2. Neoplasm Metastasis (Metastasis) : 12 outcomes 11 studies in 88 results
  3. Hepatocellular Carcinoma (Hepatoma) : 6 outcomes 6 studies in 42 results
  4. Acoustic Neuroma (Acoustic Neurinoma) : 6 outcomes 1 study in 26 results
  5. Carcinoma (Carcinomatosis) : 5 outcomes 13 studies in 67 results
Show All >>

Drugs Related to Gadolinium DTPA

  1. Gadolinium DTPA (Magnevist)
  2. Gadolinium
  3. gadobenic acid (gadobenate dimeglumine)
  4. Pentetic Acid (DTPA)
  5. gadobutrol
  6. Contrast Media
  7. Cystamine
  8. gadodiamide (Omniscan)
  9. Liposomes (Liposome)
  10. ferumoxides (Feridex)
Show All >>

Therapies Related to Gadolinium DTPA

  1. Intravenous Injections
  2. Stents
  3. Radiotherapy
  4. Diskectomy (Discectomy)
  5. Intravenous Infusions
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.